XML 43 R36.htm IDEA: XBRL DOCUMENT v3.21.4

SHARE CAPITAL - Disclosure of share based payments included in the consolidated statements of comprehensive loss (Details) - CAD ($)	4 Months Ended	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2021	Sep. 30, 2020
Disclosure of classes of share capital [line items]
Share-based compensation expense	$ 0	$ 880,615	$ 161,300
Consulting fees [Member]
Disclosure of classes of share capital [line items]
Share-based compensation expense	0	8,045	0
Directors' compensation [Member]
Disclosure of classes of share capital [line items]
Share-based compensation expense	0	136,612	0
Marketing, advertising and investor relations [Member]
Disclosure of classes of share capital [line items]
Share-based compensation expense	0	3,696	0
Professional fees [Member]
Disclosure of classes of share capital [line items]
Share-based compensation expense	0	23,126	0
Research and development [Member]
Disclosure of classes of share capital [line items]
Share-based compensation expense	$ 0	$ 709,136	$ 161,300

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfClassesOfShareCapitalLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of expense from share-based payment transactions with employees.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2020-01-01
-Paragraph 112
-Subparagraph c
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	drug_ConsolidatedStatementsOfComprehensiveIncomeLossStatementLocationAxis=drug_ConsultingFeesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_ConsolidatedStatementsOfComprehensiveIncomeLossStatementLocationAxis=drug_DirectorsCompensationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_ConsolidatedStatementsOfComprehensiveIncomeLossStatementLocationAxis=drug_MarketingAdvertisingAndInvestorRelationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_ConsolidatedStatementsOfComprehensiveIncomeLossStatementLocationAxis=drug_ProfessionalFeesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_ConsolidatedStatementsOfComprehensiveIncomeLossStatementLocationAxis=drug_ResearchAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: